Polku Therapeutics Oy
3414544-3ActiveDeveloping novel therapies for debilitating neurodegenerative diseases.
Oversikt
- Ukjent
- Ansatte
- Ukjent
- Omsetning
- 2024
- Grunnlagt
Nøkkelbeslutningstakere
Sebastian Soidinsalo
Board member
Milla Koistinaho
Board Member
Erik Wallén
Scientific Co-founder
Simon Bennett
Chief Executive Officer
+4 flere kontakter i Funnelfeedr
Beskrivelse
Polku Therapeutics is an emerging, Helsinki-based biotechnology company focused on developing innovative medicines. Their primary mission is to create first-in-class, disease-modifying therapies aimed at slowing or stopping neurodegenerative diseases. The company specifically targets debilitating co...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- 16
- MVA-nummer
- FI34145443
Beslutningstakere
8 kontakter i FunnelfeedrSebastian Soidinsalo
Board member
Milla Koistinaho
Board Member
Erik Wallén
Scientific Co-founder
Simon Bennett
Chief Executive Officer
Timo Myöhänen
Scientific Co-founder
Sara Kangaspeska
Board Member
Rouslan Michtchenko
Chairman of the Board
Andre kontakter
Varga Abendeguz
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Grespo AB
0 ansatteYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
ScandiBio Therapeutics AB
0 ansatteAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
HERANTIS PHARMA OYJ
0 ansatteDeveloping disease-modifying therapies for Parkinson's disease progression.
AlzeCure Pharma AB
10–19 ansatteSwedish pharma developing CNS drugs for Alzheimer's and pain.
BioArctic Finland Oy
Swedish biopharma developing treatments for neurodegenerative diseases.
Utforsk mer
Spørsmål om Polku Therapeutics Oy
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo